Cao Zi-yu, Ma Dong-hong. Histone modification in diabetic nephropathy[J]. Journal of Clinical Nephrology, 2022, 22(1): 77-81. DOI: 10.3969/j.issn.1671-2390.2022.01.015
    Citation: Cao Zi-yu, Ma Dong-hong. Histone modification in diabetic nephropathy[J]. Journal of Clinical Nephrology, 2022, 22(1): 77-81. DOI: 10.3969/j.issn.1671-2390.2022.01.015

    Histone modification in diabetic nephropathy

    • Diabetic nephropathy(DN) is a clinical syndrome characterized by persistent proteinuria and progressive decline in renal function. It is a typical glomerular disease. The incidence is rising yearly and it has become the most common cause of end-stage renal disease. It is particularly important to elucidate the underlying pathogenesis of DN. A growing body of evidence has demonstrated that the pathogenesis of DN is not only regulated by classical signaling pathways, but also by such epigenetic mechanisms as histone modification, DNA methylation and non-coding RNA. With the continuous discovery of research, the role of histone modification in the pathogenesis of DN has come into spotlightr. This review summarized the role of histone modifications in the pathogenesis of DN and the therapeutic prospects for DN.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return